A roundup of the most newsworthy healthcare press releases from PR Newswire, including new company mergers, Alzheimer's ...

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- With thousands of press releases published each month, it can be difficult to keep up ...

The FDA agreed with Vanda's position that motion sickness is an acute, self-limiting physiologic response rather than a chronic or chronic-intermittent condition. The Agency there ...

A millionaire developer has won a legal stoush with council to swing a wrecking ball at his $8m “magnificent estate” which ...

Tradipitant could become the first new pharmacologic treatment for motion sickness in over 40 years.